CRISPR Therapeutics AG Total Non Current Liabilities 2011-2025 | CRSP

Annual Total Non Current Liabilities CRISPR Therapeutics AG

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	70.2 M	69.1 M	69 M	90.1 M	178 M	6.36 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
178 M	6.36 M	80.5 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.89	3.82 %	$ 812 M	Canada
Aclaris Therapeutics ACRS	5.95 M	$ 3.22	-1.08 %	$ 249 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Aptevo Therapeutics APVO	5 M	$ 1.07	-5.31 %	$ 295 K	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	101 M	$ 213.6	-3.09 %	$ 5 B	Danmark
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.1	-5.53 %	$ 7.46 B	Australia
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
BioVie BIVI	62.5 K	$ 1.43	-1.72 %	$ 2.11 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	341 M	$ 93.97	-0.89 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 26.35	4.25 %	$ 1.28 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	26.1 M	$ 9.62	0.63 %	$ 141 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.26	-8.44 %	$ 566 M	Israel
Catalyst Biosciences CBIO	981 K	$ 13.28	-5.78 %	$ 874 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	107 M	$ 550.6	-2.43 %	$ 41.7 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.37	3.04 %	$ 14.9 M	USA
AstraZeneca PLC AZN	30.8 B	$ 91.34	1.68 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	17.3 M	$ 27.0	-1.85 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 11.3	-2.04 %	$ 731 M	USA
Biogen BIIB	9.03 B	$ 175.09	0.57 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	6.69 M	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 87.9	-0.1 %	$ 9.07 B	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 24.31	2.92 %	$ 2.88 B	USA
ADiTx Therapeutics ADTX	858 K	$ 1.6	-28.57 %	$ 21.1 K	USA
Cellectar Biosciences CLRB	422 K	$ 3.33	-8.01 %	$ 40.7 M	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA